309 related articles for article (PubMed ID: 27549029)
1. Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries.
Thorpe CT; Fowler NR; Harrigan K; Zhao X; Kang Y; Hanlon JT; Gellad WF; Schleiden LJ; Thorpe JM
J Am Geriatr Soc; 2016 Sep; 64(9):1806-14. PubMed ID: 27549029
[TBL] [Abstract][Full Text] [Related]
2. Association of Antidementia Therapies With Time to Skilled Nursing Facility Admission and Cardiovascular Events Among Elderly Adults With Alzheimer Disease.
San-Juan-Rodriguez A; Zhang Y; He M; Hernandez I
JAMA Netw Open; 2019 Mar; 2(3):e190213. PubMed ID: 30821828
[TBL] [Abstract][Full Text] [Related]
3. Effect of Medicare Part D on Ethnoracial Disparities in Antidementia Medication Use.
Lind KE; Hildreth K; Lindrooth R; Morrato E; Crane LA; Perraillon MC
J Am Geriatr Soc; 2018 Sep; 66(9):1760-1767. PubMed ID: 30095169
[TBL] [Abstract][Full Text] [Related]
4. Treatment Patterns with Antidementia Drugs in the United States: Medicare Cohort Study.
Koller D; Hua T; Bynum JP
J Am Geriatr Soc; 2016 Aug; 64(8):1540-8. PubMed ID: 27341454
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities.
Barthold D; Joyce G; Ferido P; Drabo EF; Marcum ZA; Gray SL; Zissimopoulos J
J Alzheimers Dis; 2020; 76(2):579-589. PubMed ID: 32538845
[TBL] [Abstract][Full Text] [Related]
6. Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction.
Lauffenburger JC; Robinson JG; Oramasionwu C; Fang G
Circulation; 2014 Feb; 129(7):754-63. PubMed ID: 24326988
[TBL] [Abstract][Full Text] [Related]
7. The impact of Medicare prescription drug coverage on the use of antidementia drugs.
Fowler NR; Chen YF; Thurton CA; Men A; Rodriguez EG; Donohue JM
BMC Geriatr; 2013 Apr; 13():37. PubMed ID: 23621892
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Dementia Treatment and Frank Prescribing Errors in Older Adults With Parkinson Disease.
Mantri S; Fullard M; Gray SL; Weintraub D; Hubbard RA; Hennessy S; Willis AW
JAMA Neurol; 2019 Jan; 76(1):41-49. PubMed ID: 30285047
[TBL] [Abstract][Full Text] [Related]
9. Racial and ethnic disparities in the treatment of dementia among Medicare beneficiaries.
Zuckerman IH; Ryder PT; Simoni-Wastila L; Shaffer T; Sato M; Zhao L; Stuart B
J Gerontol B Psychol Sci Soc Sci; 2008 Sep; 63(5):S328-33. PubMed ID: 18818454
[TBL] [Abstract][Full Text] [Related]
10. Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries.
Colantonio LD; Huang L; Monda KL; Bittner V; Serban MC; Taylor B; Brown TM; Glasser SP; Muntner P; Rosenson RS
JAMA Cardiol; 2017 Aug; 2(8):890-895. PubMed ID: 28423147
[TBL] [Abstract][Full Text] [Related]
11. Trends in Antihypertensive Medication Discontinuation and Low Adherence Among Medicare Beneficiaries Initiating Treatment From 2007 to 2012.
Tajeu GS; Kent ST; Kronish IM; Huang L; Krousel-Wood M; Bress AP; Shimbo D; Muntner P
Hypertension; 2016 Sep; 68(3):565-75. PubMed ID: 27432867
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease medication use and adherence patterns by race and ethnicity.
Olchanski N; Daly AT; Zhu Y; Breslau R; Cohen JT; Neumann PJ; Faul JD; Fillit HM; Freund KM; Lin PJ
Alzheimers Dement; 2023 Apr; 19(4):1184-1193. PubMed ID: 35939325
[TBL] [Abstract][Full Text] [Related]
13. Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.
Lampela P; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
J Alzheimers Dis; 2020; 73(3):1243-1251. PubMed ID: 31929157
[TBL] [Abstract][Full Text] [Related]
14. Effects of Medicare Part D medication therapy management on racial/ethnic disparities in adherence to antidementia medications among patients with Alzheimer's disease and related dementias: An observational study.
Dong X; Tsang CCS; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Browning JA; Garuccio J; Zeng R; Wang J
Explor Res Clin Soc Pharm; 2024 Mar; 13():100420. PubMed ID: 38420610
[TBL] [Abstract][Full Text] [Related]
15. Racial/ethnic disparities in the enrollment of Medication Therapy Management programs among Medicare beneficiaries with Alzheimer's disease and related dementias.
Browning JA; Tsang CCS; Zeng R; Dong X; Garuccio J; Wan JY; Chisholm-Burns MA; Finch CK; Tsao JW; Wang J
Curr Med Res Opin; 2022 Oct; 38(10):1715-1725. PubMed ID: 35852087
[TBL] [Abstract][Full Text] [Related]
16. Association Between Out-Of-Pocket Costs, Race/Ethnicity, and Adjuvant Endocrine Therapy Adherence Among Medicare Patients With Breast Cancer.
Farias AJ; Du XL
J Clin Oncol; 2017 Jan; 35(1):86-95. PubMed ID: 28034069
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment of Alzheimer's disease: effect of race and demographic variables.
Hernandez S; McClendon MJ; Zhou XH; Sachs M; Lerner AJ
J Alzheimers Dis; 2010; 19(2):665-72. PubMed ID: 20110610
[TBL] [Abstract][Full Text] [Related]
18. Race/Ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure.
Zhang Y; Baik SH
J Gen Intern Med; 2014 Apr; 29(4):602-7. PubMed ID: 24366395
[TBL] [Abstract][Full Text] [Related]
19. Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease.
Zissimopoulos JM; Barthold D; Brinton RD; Joyce G
JAMA Neurol; 2017 Feb; 74(2):225-232. PubMed ID: 27942728
[TBL] [Abstract][Full Text] [Related]
20. Disparities in Nursing Home Use and Quality Among African American, Hispanic, and White Medicare Residents With Alzheimer's Disease and Related Dementias.
Rivera-Hernandez M; Kumar A; Epstein-Lubow G; Thomas KS
J Aging Health; 2019 Aug; 31(7):1259-1277. PubMed ID: 29717902
[No Abstract] [Full Text] [Related]
[Next] [New Search]
